日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Complement-mediated ADCP as a distinct and finite cytotoxic mechanism of monoclonal antibodies

补体介导的ADCP作为单克隆抗体的一种独特且有限的细胞毒性机制

Van Wagoner, Carly M; Pinney, Jonathan J; Sovinski, Hanna M; Ransegnola, Brett P; Jaimes-Delgadillo, Nydia; Chu, Charles C; Zent, Clive S; Elliott, Michael R

Hairy cell leukemia variant and WHO classification correspondence Re: 5(th) edition WHO classification haematolymphoid tumors: lymphoid neoplasms

毛细胞白血病变异型与WHO分类的对应关系:第五版WHO血液淋巴瘤分类:淋巴瘤

Grever, Michael; Andritsos, Leslie; Anghelina, Mirela; Arons, Evgeny; Banerji, Versha; Barrientos, Jacqueline; Bhat, Seema A; Blachly, James; Broccoli, Alessandro; Call, Timothy; Dearden, Claire; Dietrich, Sascha; Else, Monica; Epperla, Narendranath; Fagarasanu, Andrei; Falini, Brunangelo; Forconi, Francesco; Gozzetti, Alessandro; Hampel, Paul; Hermel, David J; Iyengar, Sunil; Johnston, James B; Juliusson, Gunnar; Kreitman, Robert J; Lauria, Francesco; Lozanski, Gerard; Oakes, Christopher C; Parikh, Sameer A; Park, Jae; Quest, Graeme; Rai, Kanti; Ravandi, Farhad; Robak, Tadeusz; Rogers, Kerry A; Saven, Alan; Seymour, John F; Tadmor, Tamar; Tallman, Martin S; Tam, Constantine S; Tiacci, Enrico; Troussard, Xavier; Wörmann, Bernhard; Zent, Clive S; Zenz, Thorsten; Zinzani, Pier Luigi

Response-adapted, time-limited venetoclax, umbralisib, and ublituximab for relapsed/refractory chronic lymphocytic leukemia

针对复发/难治性慢性淋巴细胞白血病的响应适应性、限时维奈托克、乌布拉利西布和乌布妥昔单抗治疗

Hill, Brian T; Ma, Shuo; Zent, Clive S; Baran, Andrea M; Wallace, Danielle S; Advani, Anjali; Winter, Allison; Winter, Jane; Gordan, Leo; Karmali, Reem; Liesveld, Jane L; Mulford, Deborah A; Rowland, Chris; Bui, Andrew; Sportelli, Peter; Miskin, Hari P; Weiss, Michael S; Friedberg, Jonathan W; Barr, Paul M

Antibody-mediated phagocytosis in cancer immunotherapy

抗体介导的吞噬作用在癌症免疫治疗中的作用

Van Wagoner, Carly M; Rivera-Escalera, Fátima; Jaimes-Delgadillo, Nydia C; Chu, Charles C; Zent, Clive S; Elliott, Michael R

Acalabrutinib and high-frequency low-dose subcutaneous rituximab for initial therapy of chronic lymphocytic leukemia

阿卡替尼联合高频低剂量皮下注射利妥昔单抗用于慢性淋巴细胞白血病的初始治疗

Wallace, Danielle S; Zent, Clive S; Baran, Andrea M; Reagan, Patrick M; Casulo, Carla; Rice, Geoffrey; Friedberg, Jonathan W; Barr, Paul M

Arrhythmogenic Cardiotoxicity Associated With Contemporary Treatments of Lymphoproliferative Disorders

与淋巴增生性疾病现代治疗相关的致心律失常性心脏毒性

Sherazi, Saadia; Schleede, Susan; McNitt, Scott; Casulo, Carla; Moore, Jeremiah E; Storozynsky, Eugene; Patel, Arpan; Vidula, Neelima; Aktas, Mehmet K; Zent, Clive S; Goldenberg, Ilan

Rituximab induced cytokine release with high serum IP-10 (CXCL10) concentrations is associated with infusion reactions

利妥昔单抗诱导的细胞因子释放伴高血清IP-10(CXCL10)浓度与输注反应相关。

Moore, Jeremiah E; Bloom, Paige C; Chu, Charles C; Bruno, Jennifer E; Herne, Christine A; Baran, Andrea M; Quataert, Sally A; Mosmann, Timothy R; Taylor, Ronald P; Wallace, Danielle S; Elliott, Michael R; Barr, Paul M; Zent, Clive S

Risk of New-Onset Atrial Fibrillation Associated With Targeted Treatment of Lymphoma

淋巴瘤靶向治疗相关的新发房颤风险

Ojo, Amole; Goldenberg, Ilan; McNitt, Scott; Schleede, Susan; Casulo, Carla; Zent, Clive S; Moore, Jeremiah; Soniwala, Mujtaba; Aktas, Mehmet K; Sherazi, Saadia

Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia

关于毛细胞白血病中可测量残留病灶的国际专家组共识意见

Ravandi, Farhad; Kreitman, Robert J; Tiacci, Enrico; Andritsos, Leslie; Banerji, Versha; Barrientos, Jacqueline C; Bhat, Seema A; Blachly, James S; Broccoli, Alessandro; Call, Timothy; Chihara, Dai; Dearden, Claire; Demeter, Judit; Dietrich, Sasha; Else, Monica; Epperla, Narendranath; Falini, Brunangelo; Forconi, Francesco; Gladstone, Douglas E; Gozzetti, Alessandro; Iyengar, Sunil; Johnston, James B; Jorgensen, Jeffrey; Juliusson, Gunnar; Lauria, Francesco; Lozanski, Gerard; Parikh, Sameer A; Park, Jae H; Polliack, Aaron; Quest, Graeme; Robak, Tadeusz; Rogers, Kerry A; Saven, Alan; Seymour, John F; Tadmor, Tamar; Tallman, Martin S; Tam, Constantine S; Thompson, Philip A; Troussard, Xavier; Zent, Clive S; Zenz, Thorsten; Zinzani, Pier Luigi; Wörmann, Bernhard; Rai, Kanti; Grever, Michael

The highly selective Bruton tyrosine kinase inhibitor acalabrutinib leaves macrophage phagocytosis intact

高选择性布鲁顿酪氨酸激酶抑制剂阿卡替尼不会影响巨噬细胞的吞噬作用。

Pinney, Jonathan J; Blick-Nitko, Sara K; Baran, Andrea M; Peterson, Derick R; Whitehead, Hannah E; Izumi, Raquel; Munugalavadla, Veerendra; Van DerMeid, Karl R; Barr, Paul M; Zent, Clive S; Elliott, Michael R; Chu, Charles C